Your browser doesn't support javascript.
loading
Study on the effect of short course chemotherapy combined with broncho-vaxom on the prognosis of new smear positive pulmonary tuberculosis patients / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy ; (12): 87-91, 2018.
Article in Chinese | WPRIM | ID: wpr-701664
ABSTRACT
Objective To investigate the effect of short course chemotherapy combined with broncho-vaxom on the prognosis of new smear positive pulmonary tuberculosis patients.Methods 80 patients with new smear positive pulmonary tuberculosis were selected as the research subjects.According to the random number table method,they were divided into observation group and control group,40 cases in each group.The control group was treated with 2HRZE/4HR chemotherapy,the observation group was treated with broncho-vaxom tablets based on the treatment of the control group.After 6 months of treatment,the sputum negative conversion rate,pulmonary lesions absorption,the incidence rate of adverse reaction and immune function were compared between the two groups.Results After 2,4,6 months of treatmentt,the sputum negative conversion rates of the observation group were 90.00%,95.00% and 97.50%,respectively,which were significantly higher than those of the control group(x2 =4.020,4.114,3.914,all P < 0.05).After 2,6 months of treatment,the total effective rates of the observation group were 87.50% and 97.50%,which were significantly higher than those of the control group (x2 =4.588,5.000,all P < 0.05).After 6 months of treatment,the IgA,IgG,IgM,CD3+,CD4+,CD4+/CD8+ in the observation group were (70.24 ± 6.19) %,(46.89 ± 6.25) %,(2.21 ± 0.39),(3.86 ± 1.43) g/L,(14.76 ± 2.58) g/L,(1.47 ± 0.65) g/L,respectively,which were significantly higher than those of the control group(t =-2.116,-2.575,-2.322,-2.138,-4.513,-2.599,all P < 0.05),the CD8+ was (18.85 ± 2.08) %,which was significantly lower than that in the control group (t =2.609,P < 0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups (x2 =0.251,P > 0.05).Conclusion Short course chemotherapy regimen combined with bronchovaxom can improve the new smear positive pulmonary tuberculosis patients with recent sputum negative conversion rate and lung lesions absorption effect,improve the immune function of patients and without increasing the incidence of adverse reactions,it is worthy of clinical attention.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: Chinese Journal of Primary Medicine and Pharmacy Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: Chinese Journal of Primary Medicine and Pharmacy Year: 2018 Type: Article